dabigatran has been researched along with Colonic Polyps in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amano, Y; Fujishiro, H; Harada, H; Hayasaka, K; Iwaki, T; Katsuyama, Y; Kushiyama, Y; Maeda, G; Miyaoka, Y; Murakami, D; Nakahara, R; Ujihara, T; Yuki, T | 1 |
| Chan, FK; Guo, CL; Lam, KL; Lau, LH; Mak, JW; Ng, SC; Wong, GL; Wong, SH; Yip, TC | 1 |
2 other study(ies) available for dabigatran and Colonic Polyps
| Article | Year |
|---|---|
Postpolypectomy bleeding of colorectal polyps in patients with continuous warfarin and short-term interruption of direct oral anticoagulants.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Colonic Polyps; Dabigatran; Hemorrhage; Humans; Male; Pyridones; Rivaroxaban; Warfarin | 2021 |
Risks of post-colonoscopic polypectomy bleeding and thromboembolism with warfarin and direct oral anticoagulants: a population-based analysis.
Topics: Aged; Anticoagulants; Blood Transfusion; Cohort Studies; Colonic Polyps; Colonoscopy; Dabigatran; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Hong Kong; Humans; Male; Postoperative Complications; Pyrazoles; Pyridones; Retrospective Studies; Risk Assessment; Rivaroxaban; Thromboembolism; Warfarin | 2022 |